OP0024 Use of novel patient-derived xenografts and molecular subtyping to improve precision medicine in high-grade serous ovarian cancer. - Heong, V.; Topp, M.; Rutkowski, R.; Ananda, S.; Wong, S.; Swisher, E.; Lindeman, G.; Haber, M.; Norris, M. D.; Haluska, P.; Wakefield, M.; Bowtell, D.; et al. (European Journal of Cancer, 2014)